XML 71 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations Information (Tables)
12 Months Ended
Dec. 31, 2023
Consolidated Statements of Operations Information  
Schedule of group's revenue

Years ended December 31:

    

2023

    

2022

    

2021

Royalty, goods and products and services

$

43,330

$

52,218

$

60,201

Interest

 

3,717

 

3,712

 

405

Dividends

146

268

244

Other, including medical and real estate sectors

7,751

7,491

10,441

Revenue

$

54,944

$

63,689

$

71,291

Schedule of group's costs of sales and services comprised

Years Ended December 31:

    

2023

    

2022

    

2021

Royalty, goods and products and services

$

12,689

$

23,677

$

22,933

Reversal of write-down of inventories

(27)

(21)

(19)

Gain on derivative contracts, net

(1,376)

Net fair value loss (gain) on investment property and real estate for sale

59

(96)

(407)

Gain on disposition of a subsidiary

(264)

Gains on settlements and derecognition of liabilities

(1,313)

(69)

(390)

Change in fair value of loan payable measured at FVTPL

360

141

1,616

Losses on securities, net

2,794

2,436

2,320

Other, including medical and real estate sectors

4,512

4,078

6,241

Total costs of sales and services

$

19,074

$

29,882

$

30,918

Schedule of Gain on Disposition of subsidiaries

Years ended December 31:

    

2023

    

2022

    

2021

Net liabilities in excess of considerations received

 

$

 

$

(273)

 

$

Reclassification adjustment for the exchange differences upon disposition of a subsidiary

9

Gain on disposition of a subsidiary (see Note 27)

 

$

 

$

(264)

 

$

Schedule of costs of sales and services

Years ended December 31:

    

2023

    

2022

    

2021

Inventories as costs of goods sold (including depreciation expenses allocated to costs of goods sold)

$

40

$

80

$

3,488

Schedule of selling, general and administrative expenses

Years ended December 31:

    

2023

    

2022

    

2021

Compensation (wages and salaries)

$

5,418

$

4,443

$

4,551

Legal and professional

 

7,242

 

6,983

6,395

Accounting

1,646

885

1,238

Consulting and fees

3,095

6,529

3,423

Depreciation and amortization

932

784

481

Office

804

748

948

Reimbursement of expenses (net of recovery)

886

5,607

1,018

Other

4,159

*

2,501

3,090

$

24,182

$

28,480

$

21,144

*Including expenses of $542 relating to a planned acquisition which was terminated in 2023.

Schedule of nature of expenses incurred in continuing operations

Years Ended December 31:

    

2023

    

2022

    

2021

Depreciation, depletion and amortization

$

7,929

$

10,699

$

11,023

Employee benefits expenses*

 

8,057

 

7,194

 

6,922

Expenses for defined contribution plans and similar plans

227

278

253

Termination benefits

394

*Employee benefits expenses do not include the directors’ fees of the Company. For directors’ fees, see Note 24.